Released June 04, 2021 | BEIJING
en
Researched by Industrial Info Resources (Sugar Land, Texas)--India's massive COVID-19 outbreak has led to a serious decline in factory production, according to Germany's Economic Weekly, particularly in the nation's Pharmaceutical & Biotech Industry. The operating rate of Indian pharmaceutical traders and active pharmaceutical ingredient (API) companies is only about 30%.
One possible result of this trend is new opportunities for China's pharma market, which could expand its production capacity and take a larger share of the global market. APIs and generic drugs are among the products that could be most affected.
Industrial Info is tracking 476 active API projects in China, worth more than $23 billion, including 243 grassroot projects and 197 plant-expansion projects. The largest investment is from Wuxi AppTec, which is spending $1.19 billion on API projects.
Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list.
Click on the image at right for a heat map of China's active API projects, from Industrial Info's Geolocator tool.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
One possible result of this trend is new opportunities for China's pharma market, which could expand its production capacity and take a larger share of the global market. APIs and generic drugs are among the products that could be most affected.
Industrial Info is tracking 476 active API projects in China, worth more than $23 billion, including 243 grassroot projects and 197 plant-expansion projects. The largest investment is from Wuxi AppTec, which is spending $1.19 billion on API projects.
Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list.
Click on the image at right for a heat map of China's active API projects, from Industrial Info's Geolocator tool.Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
